- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 08, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,601 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AVLL3 | R$3.78 | 2.7% | 29.5% | R$738.3m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
APLT | US$4.71 | 6.1% | 185.5% | US$550.6m | US$11.60 | PS53.8x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
DIRR3 | R$25.14 | 5.4% | 55.1% | R$4.3b | R$29.18 | PE13.1x | E26.1% | 1.9% | Consumer Durables | ||
AXSM | US$75.68 | 2.0% | -2.9% | US$3.6b | US$123.56 | PS14.3x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$5.16 | 8.6% | 21.1% | US$215.9m | US$19.00 | PS7.8x | E68.0% | n/a | Pharmaceuticals & Biotech | ||
A178320 | ₩26,300.00 | 2.9% | 49.7% | ₩976.0b | ₩31,000.00 | PS1.3x | E87.5% | 0.6% | Tech | ||
EH | US$17.73 | -0.2% | 60.2% | US$1.2b | US$25.14 | PS69x | E98.0% | n/a | Capital Goods | ||
IRISDOREME | ₹78.35 | 0.3% | 6.8% | ₹6.4b | ₹101.00 | PE58.4x | E51.4% | n/a | Consumer Durables | ||
5038 | JP¥1,447.00 | 7.7% | -29.5% | JP¥21.7b | n/a | PE35.4x | E24.7% | n/a | Healthcare | ||
533286 | ₹400.35 | -9.3% | 150.9% | ₹81.5b | ₹345.00 | PE28.8x | E40.9% | 1.0% | Materials | ||
688793 | CN¥32.70 | -0.8% | -1.4% | CN¥2.7b | CN¥37.52 | PS2x | E68.6% | 0% | Household | ||
666 | HK$15.46 | -2.3% | n/a | HK$35.2b | HK$16.93 | PS2.4x | E97.0% | n/a | Capital Goods | ||
526 | CN¥65.55 | 1.6% | 162.5% | CN¥8.0b | CN¥63.49 | PE66.7x | E36.9% | n/a | Consumer Services | ||
517146 | ₹334.05 | -10.2% | 43.7% | ₹101.8b | ₹471.00 | PE24x | E26.1% | 0.8% | Materials | ||
3029 | CN¥27.08 | -1.8% | -13.9% | CN¥5.3b | n/a | PS12.8x | E69.2% | 0% | Software | ||
300896 | CN¥218.76 | 1.8% | -39.6% | CN¥65.8b | CN¥315.86 | PE33.4x | E25.2% | 1.5% | Pharmaceuticals & Biotech | ||
NVG | zł2.15 | 7.5% | 32.7% | zł75.3m | zł3.71 | PE14.9x | E29.0% | n/a | Diversified Financials | ||
ATAKP | ₺44.30 | -5.7% | n/a | ₺6.3b | ₺67.66 | PE20.8x | E72.8% | n/a | Food, Beverage & Tobacco | ||
9992 | HK$36.00 | 3.7% | 85.8% | HK$47.7b | HK$32.85 | PE40.7x | E23.2% | 0.8% | Retail | ||
A247540 | ₩220,500.00 | -5.4% | -0.7% | ₩21.5t | ₩232,080.00 | PS3.1x | E37.8% | 0% | Capital Goods | ||
NEWBRY | kr3.06 | -5.6% | -43.3% | kr74.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
A108860 | ₩17,250.00 | 3.1% | -3.4% | ₩464.3b | n/a | PS8.8x | E98.9% | n/a | Software | ||
KEBNI B | kr1.48 | -3.0% | 43.5% | kr402.4m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
CALTX | kr112.00 | 3.0% | -13.0% | kr6.0b | kr208.00 | PS5x | E49.9% | n/a | Pharmaceuticals & Biotech |